Nicole Lemerond is a public company board director and healthcare financial executive with over 25 years of experience in investment management, private equity, investment banking, mergers/acquisitions, and leveraged finance. She has significant experience executing complex transactions, managing diligence processes, raising capital and structuring balance sheets. Her breadth of industry expertise includes providers, payors, medical device manufacturers, HCIT providers, pharmaceutical and life sciences companies.

Ms. Lemerond joined the board of GeoVax in August 2022 and is a member of the Audit Committee.  She also serves on the boards of MediciNova and InMed Pharmaceuticals, where she chairs the Compensation Committees and is also a member of the Audit Committees.  She has significant corporate governance experience and during her tenure as a board member, she has advised companies and management teams on multiple equity financings and capital raises, various business development opportunities and the hiring / onboarding of new c-suite executives and auditors.

Ms. Lemerond has had significant experience in many different facets of finance throughout her career, working with both public and private company management teams and boards to increase stakeholder value.  She has led diligence on and executed M&A, Reg D and leveraged finance transactions, totaling over $3 billion while at Lehman Brothers and The Carlyle Group.  In addition, she established and led healthcare groups at leading investment firms in the process, raising over $1 billion of capital from institutional investors for these investment funds.

Ms. Lemerond holds a Bachelor of Science degree from Cornell University and is a CFA charter holder.